刘新泳山东大学主页平台管理系统--中文主页

科学研究

暂无内容

论文成果 More>>

. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023.
黄伯世. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicianal Chemistry, 64, 13604-13621, 2023.
黄伯世. First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 28, 1348, 2023.
郑义. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 7, 2022.
杨斐. Chiral Metal Nanoparticle Superlattices Enabled by Porphyrin-Based Supramolecular Structures. Angewandte Chemie - International Edition, 2021.
郑义. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 5, 2021.

著作成果 More>>

科研项目 More>>

暂无内容

刘新泳

教授

性别：男

在职信息：在职

所在单位：药学院

入职时间： 1991-07-01

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..